Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

microRNA-17~92 is a powerful cancer driver and a therapeutic target.

Jin HY, Lai M, Xiao C.

Cell Cycle. 2014;13(4):495-6. doi: 10.4161/cc.27784. Epub 2014 Jan 13. No abstract available.

PMID:
24419145
2.

MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways.

Jin HY, Oda H, Lai M, Skalsky RL, Bethel K, Shepherd J, Kang SG, Liu WH, Sabouri-Ghomi M, Cullen BR, Rajewsky K, Xiao C.

EMBO J. 2013 Aug 28;32(17):2377-91. doi: 10.1038/emboj.2013.178. Epub 2013 Aug 6.

3.

MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.

Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang S, Mitchel RE, Sun D, Ni J, Zhao L, Gao F, Cai J.

Int J Biol Sci. 2011 Apr 1;7(3):347-63.

4.

MicroRNA expression in lymphoma.

Lawrie CH.

Expert Opin Biol Ther. 2007 Sep;7(9):1363-74. Review.

PMID:
17727326
5.

Role of microRNA in the pathogenesis of malignant lymphoma.

Tagawa H, Ikeda S, Sawada K.

Cancer Sci. 2013 Jul;104(7):801-9. doi: 10.1111/cas.12160. Epub 2013 Apr 29. Review.

6.

[Aberrant expression of microRNA and its role in malignant lymphoma].

Tagawa H.

Rinsho Ketsueki. 2011 May;52(5):263-71. Review. Japanese. No abstract available.

PMID:
21646771
7.

Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma.

Kuppers DA, Hwang HC, Jackson AL, Linsley PS, Clurman BE, Fero ML.

PLoS One. 2011 Mar 11;6(3):e14758. doi: 10.1371/journal.pone.0014758.

8.

MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.

Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR.

Haematologica. 2012 Apr;97(4):586-94. doi: 10.3324/haematol.2011.048132. Epub 2011 Nov 18.

9.

A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.

Fassina A, Cappellesso R, Simonato F, Siri M, Ventura L, Tosato F, Busund LT, Pelizzo MR, Fassan M.

Cancer Cytopathol. 2014 Apr;122(4):274-81. doi: 10.1002/cncy.21383. Epub 2013 Dec 10.

10.

Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.

Li G, Cai M, Fu D, Chen K, Sun M, Cai Z, Cheng B.

Cell Physiol Biochem. 2012;30(6):1481-90. doi: 10.1159/000343336. Epub 2012 Dec 7.

11.

Cancer biology. A new cancer player takes the stage.

Couzin J.

Science. 2005 Nov 4;310(5749):766-7. No abstract available.

PMID:
16272095
12.

The role of miR-150 in normal and malignant hematopoiesis.

He Y, Jiang X, Chen J.

Oncogene. 2014 Jul 24;33(30):3887-93. doi: 10.1038/onc.2013.346. Epub 2013 Aug 19. Review.

PMID:
23955084
13.

Limited miR-17-92 overexpression drives hematologic malignancies.

Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV, Coffre M, Cordon-Cardo C, Aifantis I, Ibrahim S, Liu C, Koralov SB, Hernando E.

Leuk Res. 2015 Mar;39(3):335-41. doi: 10.1016/j.leukres.2014.12.002. Epub 2014 Dec 10.

14.

MicroRNA-196: critical roles and clinical applications in development and cancer.

Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q.

J Cell Mol Med. 2011 Jan;15(1):14-23. doi: 10.1111/j.1582-4934.2010.01219.x. Review.

15.

MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.

Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.

Carcinogenesis. 2013 Mar;34(3):530-8. doi: 10.1093/carcin/bgs371. Epub 2012 Nov 26.

PMID:
23188675
16.

The expression and regulation of microRNA-125b in cancers.

Huang K, Dong S, Li W, Xie Z.

Acta Biochim Biophys Sin (Shanghai). 2013 Oct;45(10):803-5. doi: 10.1093/abbs/gmt073. Epub 2013 Jun 25. Review.

PMID:
23800395
17.

Regulation of cardiac microRNAs by cardiac microRNAs.

Matkovich SJ, Hu Y, Dorn GW 2nd.

Circ Res. 2013 Jun 21;113(1):62-71. doi: 10.1161/CIRCRESAHA.113.300975. Epub 2013 Apr 26.

18.

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.

Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D, Saunders NJ, Boultwood J, Wainscoat JS, Pezzella F, Whittaker SJ, Tensen CP, Hatton CS, Lawrie CH.

Blood. 2010 Aug 19;116(7):1105-13. doi: 10.1182/blood-2009-12-256719. Epub 2010 May 6.

19.

MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.

Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW.

Clin Cancer Res. 2011 Jul 15;17(14):4761-71. doi: 10.1158/1078-0432.CCR-11-0494. Epub 2011 May 24.

20.

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.

Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1695-704. doi: 10.1073/pnas.1201516109. Epub 2012 Jun 8.

Supplemental Content

Support Center